Ophthalmic Laser Company Lumenis Receives FDA 510(k) Approval

Lumenis, an Israel-based medical laser company for ophthalmic and surgical applications, received FDA 510(k) clearance for the ResurFX, a fractional non-ablative laser module.

Advertisement

The ResurFX is part of Lumenis’ M22 platform. It uses a 1565 nm fiber laser and CoolScan scanner which create a homogeneous pattern of coagulation columns.

More Articles on Ophthalmology:
UC Irvine to Open $39M Gavin Herbert Eye Institute
7 Statistics on Rewarding Aspects of Ophthalmology Practice
Saratoga Vitreo-Retina Ophthalmology Celebrates 6k Patient Milestone

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Ophthalmology

Advertisement

Comments are closed.